Bora CDMO Bora CDMO

X

Find Merotocin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Merotocin
Also known as: Merotocin [inn], Uw3on116co, Chembl3354594, 1190083-57-8, Glycinamide, n-(4-mercapto-1-oxobutyl)-l-tyrosyl-l-isoleucyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-n-((4-fluorophenyl)methyl)glycyl-l-leucyl-, cyclic (1->5)-thioether, N-(4-sulfanylbutanoyl)-l-tyrosyl-l-isoleucyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-n-((4-fluorophenyl)methyl)glycyl-l-leucylglycinamide cyclic (1-5)-thioether
Molecular Formula
C48H68FN11O12S
Molecular Weight
1042.2  g/mol
InChI Key
PVVHQWISMVJHFK-NIFJBHDKSA-N
FDA UNII
UW3ON116CO

Merotocin has been used in trials studying the treatment of Preterm Delivery.
1 2D Structure

Merotocin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R,6S,9S,12S,15S)-6-(2-amino-2-oxoethyl)-N-[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]-9-(3-amino-3-oxopropyl)-12-[(2S)-butan-2-yl]-N-[(4-fluorophenyl)methyl]-15-[(4-hydroxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carboxamide
2.1.2 InChI
InChI=1S/C48H68FN11O12S/c1-5-27(4)42-47(71)56-32(16-17-37(50)62)44(68)57-35(21-38(51)63)45(69)58-36(25-73-18-6-7-40(65)54-34(46(70)59-42)20-28-10-14-31(61)15-11-28)48(72)60(23-29-8-12-30(49)13-9-29)24-41(66)55-33(19-26(2)3)43(67)53-22-39(52)64/h8-15,26-27,32-36,42,61H,5-7,16-25H2,1-4H3,(H2,50,62)(H2,51,63)(H2,52,64)(H,53,67)(H,54,65)(H,55,66)(H,56,71)(H,57,68)(H,58,69)(H,59,70)/t27-,32-,33-,34-,35-,36-,42-/m0/s1
2.1.3 InChI Key
PVVHQWISMVJHFK-NIFJBHDKSA-N
2.1.4 Canonical SMILES
CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSCCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N(CC3=CC=C(C=C3)F)CC(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
2.1.5 Isomeric SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSCCCC(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N(CC3=CC=C(C=C3)F)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
2.2 Other Identifiers
2.2.1 UNII
UW3ON116CO
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Merotocin [inn]

2. Uw3on116co

3. Chembl3354594

4. 1190083-57-8

5. Glycinamide, N-(4-mercapto-1-oxobutyl)-l-tyrosyl-l-isoleucyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-n-((4-fluorophenyl)methyl)glycyl-l-leucyl-, Cyclic (1->5)-thioether

6. N-(4-sulfanylbutanoyl)-l-tyrosyl-l-isoleucyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-n-((4-fluorophenyl)methyl)glycyl-l-leucylglycinamide Cyclic (1-5)-thioether

7. Unii-uw3on116co

8. Merotocin [who-dd]

9. Bdbm50044686

10. Db12932

11. Q20707133

2.4 Create Date
2014-07-21
3 Chemical and Physical Properties
Molecular Weight 1042.2 g/mol
Molecular Formula C48H68FN11O12S
XLogP3-0.4
Hydrogen Bond Donor Count11
Hydrogen Bond Acceptor Count14
Rotatable Bond Count20
Exact Mass1041.47536598 g/mol
Monoisotopic Mass1041.47536598 g/mol
Topological Polar Surface Area399 Ų
Heavy Atom Count73
Formal Charge0
Complexity1930
Isotope Atom Count0
Defined Atom Stereocenter Count7
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY